Insulet Co. (NASDAQ:PODD) Given Consensus Rating of "Buy" by

Shares of Insulet Co. (NASDAQ:PODD – Get Rating) have received an average rating of “Buy” from the fifteen analysts that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and nine have issued a buy recommendation on the company. The average […]

Related Keywords

United States , America , Raymond James , Charles Alpuche , Piper Sandler , Wayded Mcmillan , Morgan Stanley , Securities Exchange Commission , Insulet Company Profile Get Rating , Confluence Wealth Services Inc , Insulet Corporation , Nasdaq , Wells Fargo Company , Institutional Family Asset Management , Hm Payson Co , Quent Capital , Insulet Co , Get Rating , Exchange Commission , Wealth Services , Family Asset Management , Company Profile , Omnipod System , Insulet , Nasdaq Podd , Podd , Medical , 45784p10 , Ratings , Consensus ,